Allison B.
About Allison B.
Allison B. is a Senior Research Associate at Nektar Therapeutics, where she has worked since 2019, focusing on analytical support for biological drugs. She has a background in molecular and cellular biology and has held various research roles in the biotechnology sector.
Work at Nektar Therapeutics
Allison B. has been employed at Nektar Therapeutics since 2019, serving as a Senior Research Associate. In this role, she provides analytical support for the process characterization of biological drugs. She is responsible for generating technical documents that adhere to scientific discipline and presents scientific data to process scientists. Her work contributes to the development and characterization of innovative therapies within the organization.
Previous Experience in Biotechnology
Prior to her role at Nektar Therapeutics, Allison B. worked at several biotechnology companies. She served as a Senior Research Associate at Aduro Biotech for six months in 2018-2019. Additionally, she was a Research Associate II at Fluidigm Corporation for seven months in 2019. Her experience also includes four years as a Research Associate II at BioMarin Pharmaceutical Inc. from 2014 to 2018 and four years as a Biorepository Scientist at Roche from 2010 to 2014.
Education and Expertise
Allison B. holds a Bachelor of Science degree in Biological Sciences with an emphasis on Molecular & Cellular Biology from the University of California, Davis, where she studied from 2006 to 2010. She completed her secondary education at Carondelet High School from 2002 to 2006. Her expertise includes performing HCP ELISA, BCA protein assay, DNA quantification, and UV/VIS spectrometry, which are essential techniques in her research roles.
Scientific Contributions
In her current position at Nektar Therapeutics, Allison B. plays a key role in presenting scientific data to process scientists, which aids in decision-making and process improvements. She generates technical documents that are crucial for maintaining scientific rigor in the development of biological drugs. Her analytical support is vital for the characterization processes that ensure the efficacy and safety of new therapies.